基本信息
views: 140
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Our laboratory effort is focused on understanding scleroderma (systemic sclerosis), and developing novel therapeutic approaches based on identifying biomarkers of the disease process and utilizing biomarkers in clinical trials. We have utilized a biomarker approach in a clinical trial of fresolimumab (anti-TGF-beta) to show a role for TGF-beta in skin fibrosis associated with systemic sclerosis. More recently, we have applied single cell technologies to understand the molecular changes in stromal and inflammatory cell populations in the skin and lungs of patients with systemic sclerosis. In the skin we have discovered changes in several fibroblast populations. One of these populations, DPP4/SFRP2-expressing fibroblasts differentiate in two steps into myofibroblasts. In ongoing studies, we are identifying the alterations in chromatin structure and transcription factors regulating myofibroblast differentiation. We have carried out similar studies analyzing lungs from patients with systemic sclerosis associated interstitial lung disease. These lungs also show an emergent population of myofibroblasts, with an overlapping but distinct phenotype compared to skin myofibroblasts. We have also characterized a population of macrophages associated with progressive interstitial lung disease. We are further studying the pathways driving differentiation of both of these cell populations using single cell ATAC-seq. We anticipate that these detailed molecular understandings and in further in silico analysis in collaboration with colleagues in systems biology will lead us to better understand the cytokines communicating between cell populations promoting fibrosis, and lead to new key targets for therapeutic intervention.
Research Interests
Papers共 381 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
S. Agarwal, L. Heo, A. Chakraborty,J.D. West, K. Suresh, R.V. Nair,M.R. Nicolls,C. Morisseau, B.D. Hammock,R.A. Lafyatis, S.M. Kawut,R.T. Zamanian,
B95. SURFING IN THE GREEN ROOM: DEFINING MOLECULAR MECHANISMS OF PULMONARY VASCULAR DISEASE (2024)
ANNALS OF THE RHEUMATIC DISEASESpp.ard-2023, (2024)
EUROPEAN RESPIRATORY JOURNALno. 1 (2024): 2300088-2300088
Francesca Tirelli,Elena Pachera, Sabrina Gmur,Robert Lafyatis,Mengqi Huang,Francesco Zulian, Eva Camarillo Retamosa,Gabriela Kania,Oliver Distler
RHEUMATOLOGY (2024)
Rheumatology (Oxford, England)no. 3 (2024): 837-845
Arteriosclerosis, thrombosis, and vascular biologyno. 8 (2024): e210-e225
Sclerodermapp.247-263, (2024)
Lloyd D. Harvey,Mona Alotaibi, Hee-Jung J. Kim,Yi-Yin Tai,Ying Tang,Wei Sun,Wadih El Khoury,Chen-Shan C. Woodcock,Yassmin Al Aaraj,Claudette M. St. Croix,Donna B. Stolz, Ji Young Lee,
bioRxiv the preprint server for biology (2024)
ISCIENCEno. 6 (2024): 110010-110010
Jacob S Berkowitz,Tracy Tabib,Hanxi Xiao, Gabrielle M Sadej,Dinesh Khanna,Patrizia Fuschiotti,Robert A Lafyatis,Jishnu Das
Arthritis & rheumatology (Hoboken, N.J.)no. 10 (2023): 1819-1830
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn